Annual report pursuant to Section 13 and 15(d)

Common Stock and Stock-Based Incentive Compensation Plans (Tables)

v3.25.0.1
Common Stock and Stock-Based Incentive Compensation Plans (Tables)
12 Months Ended
Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Common Shares Outstanding
Shares of common stock outstanding were as follows:
Year Ended
December 28,
2024
December 30,
2023
December 31,
2022
(In millions)
Balance, beginning of period 1,616  1,612  1,207 
Common stock issued in the acquisition of Xilinx —  —  429 
Common stock issued under employee equity plans 17  17  17 
Repurchases of common stock (6) (10) (36)
Common stock repurchases for tax withholding on equity awards (5) (4) (5)
Issuance of common stock upon warrant exercise —  — 
Balance, end of period 1,622  1,616  1,612 
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Stock-based compensation expense was allocated in the Company’s Consolidated Statements of Operations as follows:
Year Ended
December 28, 2024 December 30, 2023 December 31, 2022
  (In millions)
Cost of sales $ 21  $ 30  $ 29 
Research and development 1,079  1,002  697 
Marketing, general, and administrative 307  352  355 
Total stock-based compensation expense before income taxes 1,407  1,384  1,081 
Income tax benefit (251) (249) (179)
Total stock-based compensation expense, net of income taxes $ 1,156  $ 1,135  $ 902 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The weighted-average estimated fair value of employee stock options granted during 2024, 2023 and 2022 was $68.38, $53.72 and $44.35 per share, respectively, using the following assumptions:
December 28, 2024 December 30, 2023 December 31, 2022
Expected volatility 54.34  %
52.36% - 52.42%
51.28  %
Risk-free interest rate 3.80  %
3.93% - 4.11%
3.00  %
Expected dividends —  % —  % —  %
Expected life (in years) 4.98
4.96 - 5.04
4.75
The weighted-average grant date fair values of PRSUs granted during 2024, 2023 and 2022 were $118.98, $134.87 and $121.12, respectively, using the following assumptions:
December 28, 2024 December 30, 2023 December 31, 2022
Expected volatility
52.68% - 53.19%
51.12% - 56.22%
50.65% - 53.51%
Risk-free interest rate
3.82% - 4.41%
4.30% - 4.36%
1.14%- 3.17%
Expected dividends —  % —  % —  %
Expected term (in years)
2.48 - 3.00
2.17 - 3.00
2.07 - 3.07
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes stock option activity and related information:
Outstanding Number
of Shares
Weighted-
Average
Exercise
Price
Aggregate Intrinsic Value Weighted-Average Remaining Contractual Life
(in years)
  (In millions, except share price)
Balance as of December 30, 2023 $ 68.33 
Granted —  $ 134.27 
Forfeited —  $ 102.71 
Exercised (1) $ 22.17 
Balance as of December 28, 2024 $ 89.73  $ 81  3.92
Exercisable December 28, 2024 $ 74.61  $ 69  2.83
Schedule of Share-based Compensation, Restricted Stock Units, Activity
The following table summarizes time-based RSU activity and related information:
Number
of Shares
Weighted- Average Grant Date Fair Value
 
(In millions)
Unvested shares as of December 30, 2023 32  $ 100.65 
Granted 12  $ 141.95 
Forfeited (1) $ 107.96 
Vested (13) $ 101.35 
Unvested shares as of December 28, 2024 30  $ 116.77 
Schedule of Nonvested Performance-based Units Activity
The following table summarizes PRSU activity and related information:
  Number
of Shares
Weighted-Average
Grant Date Fair Value
(In millions)
Unvested shares as of December 30, 2023 $ 117.65 
Granted $ 118.98 
Forfeited —  $ 132.80 
Vested (1) $ 91.15 
Unvested shares as of December 28, 2024 $ 139.31 
Schedule of ESPP The weighted-average grant date fair value for the ESPP during 2024, 2023 and 2022 was $43.80, $31.11 and $24.71 per share, respectively, using the following assumptions:
December 28, 2024 December 30, 2023 December 31, 2022
Expected volatility
48.14% - 49.38%
45.74% - 49.40%
58.15% - 63.76%
Risk-free interest rate
4.42% - 5.41%
5.13% - 5.46%
1.43% - 4.52%
Expected dividends —  % —  % —  %
Expected term (in years) 0.50 0.50 0.50